Community-Acquired Pneumonia

1. Pneumonia in HIV-Infected Patients

   • Walter F. Schlech III

   Pages 305-320

2. Community-Acquired Pneumonia in the Immunocompromised Host

   • Robert H. Rubin, Jay A. Fishman

   Pages 321-335

3. Chronic Bacterial Pneumonia

   • Steven H. Kirtland, Richard H. Winterbauer

   Pages 337-349

4. Pneumonia Mimics

   • Henry Su, Richard H. Winterbauer

   Pages 351-368

5. Lung Abscess

   • Christopher W. H. Davies, Fergus V. Gleeson, Robert J. O. Davies

   Pages 369-386

6. Nonresolving Pneumonia

   • David Ost, Anna Rozenshtein, Alan Fein

   Pages 387-413

7. Community-Acquired Pneumonia Associated with Exposure to Contaminated Water

   • Todd F. Hatchette

   Pages 415-425

8. Pneumococcal Pneumonia

   • Åke Örtqvist

   Pages 427-454

9. Haemophilus influenzae

   • Larry J. Strausbaugh

   Pages 455-474

10. Community-Acquired Pneumonia: Staphylococcus aureus

    • Santiago Ewig, Antoni Torres

    Pages 475-485

11. Mycoplasma pneumoniae Pneumonia

    • Thomas M. File Jr., James S. Tan

    Pages 487-500

12. Community-Acquired Pneumonia Due to Chlamydia pneumoniae

    • Julio A. Ramirez, James T. Summersgill

    Pages 501-509

13. Legionnaires’ Disease

    • Joseph F. Plouffe

    Pages 511-520

14. Community-Acquired Aerobic Gram-Negative Bacillary Pneumonia

    • James S. Tan

    Pages 521-530

15. Community-Acquired Pneumonia Due to Nonfermenting Gram-Negative Bacilli

    • Todd F. Hatchette

    Pages 531-540

16. Miscellaneous Bacterial Causes of Community-Acquired Pneumonia

    • Todd F. Hatchette

    Pages 541-569

17. Q Fever

    • Thomas J. Marrie

    Pages 571-591

18. Viral Pneumonia Due to Influenza and Parainfluenza Viruses and Adenoviruses

    • Thomas R. Cate

    Pages 593-616

19. Respiratory Syncytial Virus Pneumonia

    • Ann R. Falsey

    Pages 617-628

20. Measles and Varicella Pneumonia

    • B. Lynn Johnston

    Pages 629-642

Pneumonia (along with influenza) is the sixth leading cause of death in adults. About 4 million adults develop pneumonia each year in the US, resulting in 64 million days of restricted activity, 39 million days of bed confinement, and 10 million days of lost work. Yet the admission rates to hospital, length of stay, investigations, antimicrobial therapy and prevention strategies vary greatly from one geographic area to the next, and the scientific basis for many of our management strategies for pneumonia is weak to nonexistent. There are over 100 microbial agents that can cause pneumonia and many of these, especially Streptococcus pneumoniae, Group A streptococcus, and Staphylococcus aureus, are in a state of flux in terms of changing antimicrobial resistance. This book is designed to provide new information about pneumonia and identify critical research questions that will come to the fore as we enter the 21st century.

• Atmen
• HIV
• Virus
• antimicrobial
• antimicrobial resistance
• antimicrobial therapy
• bacteria
• infectious diseases

• University of Alberta, Edmonton, Canada

  Thomas J. Marrie

Policies and ethics